- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cloudbreak Pharma Inc (2592)
Cloudbreak Pharma Inc stock price live, this page displays HK 2592 stock exchange data. View the 2592 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cloudbreak Pharma Inc real time stock price chart below.
What Is the Cloudbreak Pharma Inc Stock Price Today?
The Cloudbreak Pharma Inc stock price today is 5.11.
What Is the Stock Symbol for Cloudbreak Pharma Inc?
The stock symbol for Cloudbreak Pharma Inc is ""2592.""
What Stock Exchange Does Cloudbreak Pharma Inc Trade On?
Cloudbreak Pharma Inc is listed and trades on the Hong Kong stock exchange.
Is Cloudbreak Pharma Inc a Good Stock to Buy?
Determining whether Cloudbreak Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2592 quote. (ISIN: KYG2215S1084)
What Is the Cloudbreak Pharma Inc Stock Price Today?
The Cloudbreak Pharma Inc stock price today is 5.11.
What Is the Stock Symbol for Cloudbreak Pharma Inc?
The stock symbol for Cloudbreak Pharma Inc is ""2592.""
What Stock Exchange Does Cloudbreak Pharma Inc Trade On?
Cloudbreak Pharma Inc is listed and trades on the Hong Kong stock exchange.
Is Cloudbreak Pharma Inc a Good Stock to Buy?
Determining whether Cloudbreak Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2592 quote. (ISIN: KYG2215S1084)
Hong Kong
Currency in HKD
5.11
-0.09(-1.73%)
Closed·
Fair Value
An estimate of a Cloudbreak Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.10
5.20
52 wk Range
4.93
9.74
2592 Scorecard
Full Analysis
Short term obligations exceed liquid assets
2592 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Cloudbreak Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.105.20
52 wk Range
4.939.74
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2592 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Cloudbreak Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading near 52-week low
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Cloudbreak Pharma Inc Company Profile
Cloudbreak Pharma Inc., a clinical-stage ophthalmology biotechnology company, researches and develops ophthalmic drugs for chronic eye diseases. The company develops CBT-001, which is in Phase 3 clinical trial for treating pterygium; CBT-009, a topical formulation of atropine that is in Phase 1/2 study indicated for the treatment of juvenile myopia; CBT-004, a VEGF receptor inhibitor, which is in Phase 2 clinical trial for treating vascularised pinguecula; and CBT-006, a cholesterol dissolving molecule containing the active pharmaceutical ingredient of hydroxypropyl beta-cyclodextrins that is in Phase 2 clinical trial for the treatment of meibomian gland dysfunction associated dry eye disease. It also develops CBT-199 and CBT-145 for the treatment of presbyopia, a condition caused by an age-related process; CBT-007, an eye drop for enhancing success rate of glaucoma filtration surgery; and CBT-011, an antibody-drug-synergism conjugate for the treatment of diabetic macular edema. The company was founded in 2015 and is headquartered in Irvine, California.
Compare 2592 to Peers and Sector
Metrics to compare | 2592 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2592PeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.5x | −1.3x | −0.6x | |
PEG Ratio | −0.22 | −0.05 | 0.00 | |
Price/Book | - | 1.7x | 2.6x | |
Price / LTM Sales | 54.8x | 7.9x | 3.3x | |
Upside (Analyst Target) | - | 276.5% | 37.9% | |
Fair Value Upside | Unlock | 26.0% | 3.7% | Unlock |
FAQ
What Stock Exchange Does Cloudbreak Pharma Trade On?
Cloudbreak Pharma is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for Cloudbreak Pharma?
The stock symbol for Cloudbreak Pharma is "2592."
What Is the Cloudbreak Pharma Market Cap?
As of today, Cloudbreak Pharma market cap is 4.45B.
What Is Cloudbreak Pharma's Earnings Per Share (TTM)?
The Cloudbreak Pharma EPS (TTM) is -0.21.
From a Technical Analysis Perspective, Is 2592 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Cloudbreak Pharma Stock Split?
Cloudbreak Pharma has split 0 times.
How Many Employees Does Cloudbreak Pharma Have?
Cloudbreak Pharma has 51 employees.
What is the current trading status of Cloudbreak Pharma (2592)?
As of 23 Aug 2025, Cloudbreak Pharma (2592) is trading at a price of 5.11, with a previous close of 5.20. The stock has fluctuated within a day range of 5.10 to 5.20, while its 52-week range spans from 4.93 to 9.74.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.